A SIGRID researcher pipetting samples in the lab at Stockholm University

About SIGRID

Born In A Swedish Lab.
Made For Real Meals.

SIGRID is built on SiPore®, a patented technology developed over more than 15 years of research in Stockholm, Sweden. Our mission is simple: reduce the impact of modern meals, without asking you to give up the food you love.

Illustration of a porous SiPore particle with enzymes entrapped in its pores

Our origin · Stockholm University, 2007

It Started With A Different Question.

Most approaches to metabolic health focus on what to take off your plate. In 2007, Professor Tore Bengtsson and his research group at Stockholm University asked something else.

Could the digestive process itself become the place to make a difference?

That question led to precisely engineered porous silica, and to years of research into how its pores interact with digestive enzymes. The result is SiPore®: a technology that works locally in the gut and slows the breakdown of carbohydrates and fats.

Portrait of Professor Tore Bengtsson, founder of SIGRID and inventor of SiPore, in a lab coat

Our founder

Meet The Scientist Behind SiPore®.

Prof. Tore Bengtsson

Founder of SIGRID · Inventor of SiPore®

Tore is a Professor of Physiology at Stockholm University, with more than 25 years of experience in metabolic and cellular research. His work focuses on how modern eating patterns affect the body after a meal, and his research group first developed SiPore®.

Our journey

From University Research To Your Table.

Nearly two decades of materials science, mechanism studies and human research, in one Stockholm lab and beyond.

  1. 2007

    Research begins at Stockholm University. Professor Tore Bengtsson and his research group start investigating porous silica and local modulation of digestion.

  2. 2014–2020

    Mechanism and first human research. Preclinical work maps how the engineered particle interacts with digestive enzymes, followed by first-in-human safety and mechanism studies.

  3. 2021–2023

    The clinical program expands. Human studies extend the research into metabolic-health outcomes, alongside continued mechanism and materials research.

  4. 2024

    SIGRID launches in the US. SiPore® reaches American consumers for the first time.

  5. 2026

    SHINE is published. The 318-participant randomized, double-blind, placebo-controlled trial appears in eClinicalMedicine, part of The Lancet Discovery Science.

  6. Today

    Research continues in Stockholm, and SIGRID brings SiPore® to everyday meals with Glucose Stabilizer and Carb Fence™.

SHINE evaluated SiPore21, a SiPore® formulation, not SIGRID products.

Research foundation

More Than 15 Years Of Research.

Explore our science
15+
Years of research
6
Human clinical trials
9
Peer-reviewed publications
10+
Granted patents

Figures cover the full SiPore® research program, including studies of SiPore® formulations other than SIGRID products.

Our team

Science First. Then The Product.

SIGRID is made by a small, multidisciplinary team in Stockholm, with expertise in metabolic research, materials science, clinical development and product development.

The SiPore research team in lab coats in the lab at Stockholm University
The team in our lab at Stockholm University.

How we work

  1. Engineer the material

    Every SiPore® particle is precisely manufactured to control its size and pores. That structure is what gives it its function during digestion.

  2. Understand the mechanism

    We study how the particle interacts with digestive enzymes locally in the gut, without entering the bloodstream.

  3. Test in people

    We evaluate SiPore® in controlled human research, together with university and clinical research partners.

Scientific advisors

Guided By Leading Experts.

Our advisory panel brings together scientists and physicians with expertise in physiology, microbiology and materials chemistry.

  • Stephan Rössner

    Stephan Rössner

    M.D., Ph.D.

  • Kirsi Pietiläinen

    Kirsi Pietiläinen

    M.D., Ph.D.

  • Benjamin Boyd

    Benjamin Boyd

    Ph.D.

  • Jørgen Thorball

    Jørgen Thorball

    M.D., Ph.D.

  • Mikael Rydén

    Mikael Rydén

    M.D., Ph.D.

  • Arvo Hanni

    Arvo Hanni

    M.D., Ph.D.

  • Jan Lundberg

    Jan Lundberg

    Ph.D.

  • Andy Leyland

    Andy Leyland

    B.Sc. Biochemistry

Powered by SiPore®

Part Of SiPore Technologies.

SIGRID is the consumer brand of SiPore Technologies, the corporate brand of Sigrid Therapeutics AB in Stockholm, Sweden. SiPore Technologies owns and develops SiPore®, and brings it to people through SIGRID, healthcare professionals and partner brands.

Discover SiPore.com
Founded in Sweden
Sigrid Therapeutics AB
Vasagatan 14A, 172 61 Sundbyberg, Sweden
Here for you in the US
Sigrid, Inc.
70 W Madison St, Suite 5750
Chicago, IL 60602, United States

Same meal. Less impact.

Start With Your Next Meal.